GMABGENMAB A/Svs its industry peers
A metric-by-metric comparison of GENMAB A/S against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GMAB본 종목 | — | — | — | — | 19.2%#6 | -15.0%#11 | 28.6%#5 | — | — | — | 94.1%#3 | — |
| VRTX | $142.8B#4 | 32.8x#4 | 7.1x#3 | 11.9x#6 | 8.9%#8 | 838.1%#2 | 34.8%#2 | 19.5%#4 | 25.0%#3 | — | 32.4%#9 | — |
| AMGN | $250.1B#2 | 28.7x#3 | 21.4x#8 | 6.8x#3 | 10.0%#7 | 88.5%#6 | 24.7%#7 | 66.0%#1 | 15.1%#6 | — | 58.2%#6 | 2.0%#1 |
| GILD | $207.9B#3 | — | 15.9x#7 | 7.1x#4 | 2.4%#9 | 1672.9%#1 | 34.0%#3 | 65.3%#2 | 25.7%#2 | — | 42.7%#8 | 1.9%#2 |
| REGN | — | 21.3x#2 | — | — | 1.0%#11 | 2.1%#9 | 24.9%#6 | 13.4%#5 | 9.2%#8 | — | 47.6%#7 | — |
| ARGX | $54.5B#7 | — | — | 1532.4x#11 | 254.4%#1 | 55.1%#7 | 2965.7%#1 | — | — | — | 7.2%#10 | — |
| ALNY | $21.3B#12 | 8.3x#1 | 5.9x#2 | 5.7x#2 | 65.2%#3 | 212.8%#3 | 13.5%#9 | 8.7%#7 | 19.3%#5 | — | — | — |
| NTRA | $56.8B#6 | — | 31.2x#9 | 24.6x#7 | 35.9%#5 | -9.3%#10 | -13.4%#11 | -11.4%#9 | -18.0%#9 | — | — | — |
| RVMD | $40.4B#8 | — | 15.5x#6 | — | — | -88.5%#14 | — | -43.4%#11 | — | — | 220.3%#2 | — |
| BIIB | $37.1B#9 | 108.7x#6 | 2.5x#1 | 3.8x#1 | 2.2%#10 | -20.8%#12 | 28.7%#4 | 8.7%#6 | 12.3%#7 | 3#3 | 62.6%#5 | — |
| ILMN | $34.4B#10 | 39.2x#5 | 10.9x#4 | 7.9x#5 | -0.7%#12 | 169.5%#4 | 18.6%#8 | 27.0%#3 | 19.9%#4 | 8#1 | 84.3%#4 | — |
| MRNA | $89.0B#5 | — | 13.2x#5 | 45.8x#9 | -39.9%#13 | 20.8%#8 | -158.1%#12 | -41.7%#10 | -54.6%#10 | — | 720.7%#1 | — |
| INSM | $24.1B#11 | — | 33.2x#10 | 39.8x#8 | 66.7%#2 | -39.7%#13 | -205.6%#13 | -175.8%#12 | -141.2%#11 | 3#3 | -42.0%#11 | — |
| ONC | $536.7B#1 | 844.5x#7 | 103.7x#11 | 100.5x#10 | 40.2%#4 | 144.5%#5 | 8.4%#10 | 5.5%#8 | 29.9%#1 | 6#2 | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice